以下文章来源于DT商业观察 ，作者DT商业观察 来 源丨 DT商业观察（ID： DTcaijing ） 作者丨 孟萍萍 编辑丨 张晨阳 " 戴动态血糖仪两个月，居然瘦了 6斤！" "我宣布动态血糖仪是最好的减肥伴侣。" DT商业观察 . 第一财经旗下年轻态财经商业媒体。关注消费、互联网、电商、文娱、科技、城市等领域，融合媒体和 研究机构的禀赋，厘清趋势和商业间的关系，用年轻化的视角认识商业世界。 "不打针不吃药的健康减肥方法，恐怕只有佩戴动态血糖仪……" 小红书上，原本属于专业医疗范畴的血糖仪，正被一群年轻人 "玩"成了减肥、控糖、健康管理神 器。 他们热衷于分享自己佩戴动态血糖仪（持续葡萄糖监测仪 ， 也称 CGM，以下统称动态血糖仪） 后，身体对一杯奶茶、一碗米饭、甚至一颗荔枝的真实反应。 海量的分享 笔记中， "血糖刺客""升糖炸弹""稳糖食物"等 概念 层出不穷，评论区 网友热烈 地讨 论着 "胡萝卜和燕麦奶哪个才是真正的'血糖杀手'"。 2024年 以来， "血糖仪" 的 社媒声量越来越高， 去年 4月 #90 %的年轻人担心自己有病#的微博 热搜下，不少人就在讨论血糖仪；11月14日世界糖尿病日当 ...

Core Viewpoint - The establishment of Peianmei (Zhejiang) Technology Co., Ltd. marks a significant collaboration between a technology company and the local government, aiming to innovate the healthcare service system through advanced technologies like medical models and brain-machine interfaces [1][2]. Group 1: Company Development - Peianmei was founded in September 2024 with a vision to integrate health management into daily life, supported by a diverse group of stakeholders including state-owned enterprises and universities [2][3]. - Within nine months, Peianmei has rapidly advanced in the health technology sector, establishing partnerships with various universities and institutions to develop innovative health solutions [3][4]. Group 2: Strategic Collaborations - Peianmei has formed strategic partnerships with institutions like Northwest A&F University and Yunnan University of Traditional Chinese Medicine to explore areas such as medical nutrition and traditional medicine integration [3][4]. - The company is also collaborating with Shenzen Yintong Health Industry Co., Ltd. and Capital Medical University to innovate in brain-machine interface technologies [4][6]. Group 3: Technological Innovations - Peianmei is developing a comprehensive health ecosystem that spans prevention, diagnosis, treatment, and rehabilitation, including initiatives like the "Health One Card" platform and the "Special Medical Food Research Laboratory" [5][6]. - The company aims to leverage artificial intelligence and big data to enhance healthcare delivery and management, addressing chronic diseases and improving patient outcomes [6][9]. Group 4: Alignment with National Strategy - Peianmei's initiatives align with national strategies such as the "Artificial Intelligence +" action plan, aiming to contribute to the "Healthy China" initiative by transforming health management practices [8][9]. - The company's ultimate goal is to make health management a daily reality for individuals, emphasizing preventive care and data-driven health solutions [9].

转自：新华财经 新华财经上海7月1日电（记者 魏雨田）6月30日，if 椰子水母公司 IFBH 正式在港交所挂牌上市，首日股价即飙升42.09%，市值突破105亿港元。其背后资本 阵容颇为亮眼，包括瑞银、南方基金等11家基石机构合计注资3.1亿港元。 数据显示，中国椰子水市场年复合增速为19.4%，2029年规模有望达到26.6亿美元，包括欢乐家、泰国IMCOCO、佳果源等中外品牌正在加速布局。 6月30日，if 椰子水的母公司 IFBH Limited（股票简称：IFBH）成功登陆港股市场。新华财经数据显示，IFBH 上市首日表现亮眼，股价飙升42.09%，市值 攀升至105.33亿港元。 值得关注的是，股东名单中出现道合承光私募身影。公告显示，该私募获配84.68万股，价值2354万港元，而持有该私募30%以上股权的正是农夫山泉董事 长钟睒睒。 IFBH 的基石投资者阵容也颇为亮眼，包括瑞银集团、南方基金、广发国际、工银理财、对冲基金 Jain Global 等11家机构，合计投资金额约3.1亿港元。 此外，易方达基金旗下易方达全球医药行业（QDII）也参与港股打新，根据6月28日公告，该基金中签12.5 ...

Core Viewpoint - The article highlights the innovative marketing strategies of Guilin Sanjin and Sanjin Pian, particularly focusing on the "Urological Health Smooth Journey" campaign during the 12th anniversary of Urological Health Day on June 16, aiming to raise awareness about urinary health among a broader audience [1][15]. Group 1: Campaign Initiatives - Guilin Sanjin partnered with Didi Delivery to launch a public welfare initiative targeting drivers, addressing their unique health challenges related to prolonged sitting and inadequate hydration [3][4]. - A research report titled "Urological Health Smooth Journey - 2025 Care for Driver Groups" was published, based on surveys conducted with thousands of ride-hailing and freight drivers, to better understand their health habits and needs [6]. - A three-day themed truck parade took place from June 14-16 in key locations in Guangzhou, promoting awareness of urinary health through eye-catching slogans on custom trucks [8]. Group 2: Educational Efforts - The campaign included interactive activities such as care packages for drivers and engaging games to disseminate knowledge about urinary health [9]. - Experts in urology recorded educational videos using simple language to encourage good habits related to urinary health, alongside the release of a situational short film and an interactive H5 game to make learning more engaging [12]. Group 3: Brand Evolution - Since the inception of Urological Health Day in 2014, Guilin Sanjin has consistently evolved its marketing strategies, collaborating with various platforms to enhance public health awareness and adapt to market demands [15]. - The partnership with Didi Delivery represents a new approach to reach a specific occupational group, reinforcing the brand's commitment to improving public understanding of urinary health [15].

Core Viewpoint - The article highlights the transformation of Jiaxing from a resource-poor agricultural city to an industrial powerhouse, driven by the "Red Boat Spirit," which embodies innovation, perseverance, and dedication to the people [1][2]. Group 1: Economic Development - By 2024, Jiaxing's GDP reached 756.95 billion yuan, with industrial strength ranking third in Zhejiang province, marking its emergence as a significant economic city [2]. - The traditional manufacturing sector in Jiaxing generated an added value of 181.94 billion yuan in 2024, with a year-on-year growth of 13.3%, the highest in the province [7]. Group 2: Industry Transformation - The wool sweater industry in Honghe has evolved from a small market in the 1970s to a global hub, with over 200 companies and an annual export value exceeding 20 billion yuan [4][5]. - The rise of the chemical fiber industry in Tongxiang, led by Tongkun Group, has transformed from near bankruptcy to a global leader with revenues exceeding 200 billion yuan [5]. Group 3: Innovation and Future Industries - Jiaxing is focusing on future industries such as artificial intelligence, life health, and future energy, with established bases in third-generation semiconductors and hydrogen energy [13]. - The establishment of the Zhejiang Tsinghua Yangtze River Delta Research Institute has fostered 78 listed companies and accelerated industrial upgrades, achieving an industrial output value of 60.5 billion yuan in 2024 [9][10]. Group 4: Strategic Initiatives - The "135N" system aims to develop a global advanced manufacturing cluster and several national and regional advanced manufacturing clusters, with strategic emerging industries accounting for 44.4% of the city's industrial output in 2024 [10]. - Jiaxing's commitment to future industries is evident in its comprehensive support system, including land, talent, funds, and innovative resources [13].

证券研究报告 交易型指数基金资金流向周报 数据日期：2025/6/16-2025/6/20 长城证券产业金融研究院 基金研究 分析师：金铃 执业证书编号：S1070521040001 报告日期：2025年7月1日 交易型指数基金资金流向 www.cgws.com 国内被动股票基金 | 基金规模 | 大 类 | | 周涨跌幅 | 周资金净买入额 | 今年以来周涨跌幅走势图 | 今年以来周资金流向走势图 | | | --- | --- | --- | --- | --- | --- | --- | --- | | 所属概念 | | (亿元) | (%) | (亿元) | | | | | 上证50 | | 1594.56 | 1.69 | 2.15 | | | | | 沪深300 | | 9834.49 | 2.19 | -71.25 | | | | | 中证500 | | 1401.20 | 3.91 | -19.27 | | | | | 中证1000 | | 1169.17 | 4.63 | -9.44 | | | | | 创业板指 | | 1264.48 | 5.61 | -11.84 | | | | | 科 ...

Core Viewpoint - IFBH Limited, the parent company of if coconut water, has officially listed on the Hong Kong Stock Exchange, marking a significant milestone for the company and the coconut water market in China [2][3]. Company Overview - IFBH is rooted in Thailand and specializes in ready-to-drink beverages and ready-to-eat foods, with major brands including if and innococo. It is the second-largest coconut water beverage company globally and has dominated the Chinese coconut water market for five consecutive years since 2020 [2]. - The company achieved a rapid listing process, taking only 82 days from application to listing, which is a record for the Hong Kong market [3]. Market Performance - The initial public offering (IPO) was priced at 27.8 HKD per share, with a significant opening increase of nearly 58%, leading to a market capitalization close to 12 billion HKD [3]. - During the public offering phase, IFBH received 236,000 subscriptions, with an oversubscription rate of over 2,682.35 times, making it one of the top five oversubscribed new stocks in recent years [3]. Market Position - IFBH holds a market share of approximately 34% in the Chinese coconut water market as of 2024, significantly surpassing its nearest competitor by more than seven times [6]. - The company derives over 90% of its revenue from the Chinese market, indicating a strong dependency on this region for its financial performance [7]. Growth Potential - The coconut water market in China is projected to grow at a compound annual growth rate (CAGR) of 60.8% from 2019 to 2024, outpacing other regions [3]. - IFBH's strategic marketing efforts, including collaborations with popular brands and celebrities, have significantly boosted its visibility and sales in the Chinese market [8][10]. Business Model - IFBH operates on a light-asset model, relying on third-party manufacturers, logistics providers, and distributors, which allows the company to minimize costs and focus on product development [10][11]. - The company has only 46 employees, with a significant portion dedicated to sales, indicating a streamlined operational structure [11]. Financial Performance - In 2023, IFBH's revenue was approximately 87.44 million USD, with coconut water contributing 82.01 million USD, representing 93.8% of total revenue. For 2024, the projected revenue is 157.65 million USD, with coconut water expected to account for 95.6% [13]. - The company's revenue from the Chinese market was 79.92 million USD in 2023, projected to rise to 146 million USD in 2024, highlighting its reliance on this market [13]. Challenges - While the light-asset model has facilitated rapid growth, it poses risks related to supply chain dependency on third-party manufacturers, which could impact product quality and availability [12][14]. - The company faces potential vulnerabilities due to its heavy reliance on a single product (coconut water) and a single market (China), which could be affected by competitive pressures and market fluctuations [12][14].

Core Viewpoint - The company aims to enhance its sustainable competitive advantage through comprehensive value chain reforms, despite facing challenges in revenue and profit due to new store openings and goodwill impairment losses [1]. Group 1: Financial Performance - In 2024, the company achieved a revenue of 22.358 billion yuan, a slight decrease of 0.36% year-on-year, while the net profit attributable to shareholders was 519 million yuan, down 44.13% [1]. - The decline in net profit is attributed to the increase in the number of new stores, which are still in the performance growth phase, and the company's recognition of goodwill impairment losses [1]. Group 2: Industry Trends and Strategy - The pharmaceutical retail industry is undergoing significant transformation, shifting from rapid expansion to a phase of differentiation and consolidation [1]. - In the first quarter of 2025, the company reported a net decrease in stores, with 211 new stores opened and 236 closed, resulting in a total reduction of 25 stores [1]. - The company plans to open 1,000 stores in 2025, primarily focusing on franchise stores and converting existing stores to franchises, while also pursuing strategic acquisitions in advantageous markets [1]. Group 3: Compliance and Ecosystem Development - The company emphasizes strengthening its compliance system and self-inspection mechanisms to ensure compliant operations, aiming to enhance store operational quality [2]. - The focus is on developing franchise and alliance businesses to integrate industry resources and build an ecosystem with small and medium-sized pharmacies, aiming to capture opportunities during the industry consolidation phase and increase market share [2]. Group 4: R&D and AI Initiatives - The company has been recognized as a technology center since 2011 and allocates approximately 0.6% of its total revenue annually for R&D, focusing on product and technology development [3]. - The company has developed over 70 self-researched business system products and obtained 102 software copyrights, supporting efficient business operations [3]. - An AI application strategy committee has been established to ensure the implementation of AI initiatives across various business areas, including the development of multiple generative dialogue assistants for different scenarios [3]. Group 5: Future Outlook - The company envisions a transformation from a single "pharmaceutical sales terminal" to a "comprehensive health service complex," aiming to meet evolving consumer health demands [3]. - The strategy includes deepening professional pharmaceutical services, enhancing prescription outsourcing capabilities, and expanding diverse service scenarios through physical pharmacies to create a health community ecosystem [3].

Core Insights - The health industry in China is experiencing unprecedented growth opportunities under the "Healthy China 2030" strategy, with Guangxi Wuzhou Sweet Home Bee Industry Co., Ltd. (Sweet Home) leading the way in the bee industry through a "bee industry + three industry integration" strategy [1] Group 1: Market Trends and Innovations - The ready-to-drink health market is seeing a strong demand for "natural, functional, and convenient" products, particularly among Generation Z consumers [2] - Sweet Home's upcoming "Honey Know" honey beverage aims to address these consumer needs by combining the natural nutrition of honey with modern beverage technology, creating a product suitable for immediate consumption [2] - The product design avoids high sugar content and utilizes a modular development system to create a nutritional combination that retains the natural components of honey while enhancing taste through precise formulation [2][4] Group 2: Strategic Business Model - The "one product drives three industries" strategy is central to Sweet Home's approach, using honey beverages to simultaneously promote the development of agriculture (specialized honey source bases), breeding (standardized bee colony breeding), and water management (ecological water source protection) [4] - This model illustrates a shift in traditional agricultural processing, transforming single raw materials into strategic leverage for multi-industry collaboration [4][5] Group 3: Agricultural Integration and Technology - Sweet Home employs a "company + association (cooperative) + farmers + base" model, showcasing a typical example of deep integration in agricultural practices [5] - The company utilizes 120 IoT-equipped beekeeping vehicles across 127 apiaries, enhancing honey collection efficiency and traceability through blockchain technology, thereby improving the quality of raw materials for high-end markets [5][8] Group 4: Expansion into New Markets - Sweet Home is not only a producer of bee products but is also transitioning into a "health solution service provider," aiming to create a wellness brand that integrates innovative products, brand strengthening, and quality enhancement [7] - The company's strategy represents a significant redefinition of the bee industry's value dimensions, moving from product output to comprehensive solutions encompassing health food, eco-tourism, wellness services, and educational research [7][10]

7月1日，国家医保局、国家卫生健康委印发《支持创新药高质量发展的若干措施》（以下简称《措施》）。《措施》紧密围绕我国创新药当前面临的研发难 度大、进入医保难、医院使用受限以及支付压力大等突出问题，打通"实验室"到"病床边"全链条，提出涵盖5个方面共16条具体举措。 最具突破性的是首次提出设立"商业健康保险创新药品目录"。国家医保局医药管理司司长黄心宇在同日举行的新闻发布会上强调，国家医保局计划实现商保 创新药目录与医保目录同时申报、同步调整，程序基本一致，企业可以自主申报纳入医保药品目录、商保创新药目录或同时申报两者。 | 名称: | 国家医保局 国家卫生健康委关于印发《支持创新药高质量发展的若干措施》的通知 | | | | --- | --- | --- | --- | | 索引号: | 2025-02-00016 | 发文字号: | 医保发〔2025〕16号 | | 发布日期: | 2025-07-01 | 发布机构: | | 政策指导与统筹研发也成为研发支持的关键抓手。《措施》提出，优化医保部门企业接待机制，畅通医保部门与创新药企业沟通交流渠道，有针对性加强创 新药在药品目录准入方面的政策指导。同时，将 ...